EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 99 filers reported holding EPIZYME INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $120,000 | -54.7% | 13,766 | -38.1% | 0.01% | -67.4% |
| Q3 2020 | $265,000 | +24.4% | 22,251 | +29.4% | 0.04% | +22.9% |
| Q1 2019 | $213,000 | -38.3% | 17,201 | -32.4% | 0.04% | -32.7% |
| Q2 2018 | $345,000 | -24.8% | 25,453 | +5.6% | 0.05% | -29.7% |
| Q3 2017 | $459,000 | +341.3% | 24,104 | +136.1% | 0.07% | +164.3% |
| Q2 2016 | $104,000 | – | 10,208 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |